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Abstract: A few tightly regulated transport proteins mediate iron absorption across the 
intestinal epithelium. At the basolateral border of intestinal cells there is one identified 
transporter, ferroportin, for the transfer of intracellular iron to the vascular system. Here, 
we investigate the effects of ascorbate (vitamin C) on the regulation of ferroportin in 
human intestinal Caco-2 cells using ELISA and Western Blot analyses. The results indicate 
that ferroportin protein levels peak at 100 μM of added ascorbate with an increase of 274% 
(p = 0.02). At 150 μM of ascorbate, the increase was only 28% (p = 0.04), and at 200 μM 
there was no significant change from the baseline control. In addition, the ascorbate-induced, 
(at 150 μM) up-regulated ferroportin levels were associated with increased 55Fe transport 
across the basolateral border (19%, p = 0.03). Ascorbate-induced up-regulation of cellular 
ferroportin levels (no added iron) was associated with increased levels of the iron 
regulatory protein IRP2 (230%, p = 0.0009), and the hypoxia-inducible factor HIF2α (69%, 
p = 0.03). Thus, iron transport across the basal border via ferroportin is influenced by the 
intracellular status of ascorbate and IRP2 and HIF2α are involved. We discuss possible 
reasons for the ascorbate-effects and the dependence of cellular growth conditions for iron 
transport-related protein expression. 
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1. Introduction 
Ascorbate, the anionic form of ascorbic acid (vitamin C), is an important mediator in several 
cellular processes where it mostly functions as an electron donor in enzymatic reactions. Two 
important functions of ascorbate are to serve as a cofactor for hydroxylases required for the 
stabilization of collagen in skin [1] and the formation of the catecholamine norepinephrine [2] in the 
adrenal glands. Ascorbate is a well-known enhancer of nutritional iron uptake in the human  
intestine [3] and in human intestinal cell lines [4,5]. Until recently, this enhancement was thought to 
simply be a lumenal effect due to the reduction of ferric iron to ferrous iron by ascorbate. Ascorbate 
has been shown to possess pH-dependent chelating properties [6], forming soluble complexes [7], that 
could facilitate iron transport in the intestinal lumen. Recent studies show that ascorbate has 
intracellular effects on iron transporters and that iron increases the cellular uptake of ascorbate [8]. We 
have shown that intracellular ascorbate status affects the iron uptake related proteins DMT1 
(NRAMP2) and DCYTB in human intestinal Caco-2 cells [9]. We also observed that approximately 
50% of the increase in the intracellular iron storage protein ferritin was due to replete intracellular 
ascorbate levels. Another important observation was that expression levels of DMT1 and DCYTB 
were time dependent, showing an initial up-regulation and a later down-regulation. These data support 
the results of human studies, which indicate that continuous administration of ascorbic acid to the diet 
does not improve iron status [10]. In the light of these previous studies, it is convincing that ascorbate 
plays an important role in the absorption of iron that requires further elucidation in order to make use 
of the beneficial effects of ascorbic acid in human nutrition [11]. 
In the present study, we investigated the effects of ascorbate on the transfer of iron across the basal 
border of human intestinal Caco-2 cells. We also examined the cellular levels of the iron transporter 
ferroportin (FPN1/IREG1/SLC40A1), which is believed to be the main responsible transporter for the 
transport of ferrous iron (Fe2+) across the basal membrane of enterocytes into the portal circulation [12]. 
Ferroportin mRNA contains an iron response element (IRE) motif and like DMT1, ferritin, and the 
transferrin receptor, ferroportin is subject to iron-dependent regulation by the interaction of iron 
regulatory proteins (IRPs) with the IRE sequence [13]. Thus, ferroportin mRNA expression is 
regulated by the intracellular iron concentration. At present, there are two different IRPs identified, 
IRP1 and IRP2, which respond differently to iron. When cytosolic iron levels are low, IRP1 binds to 
IRE-motifs and either represses or promotes translation of IRE-containing mRNA. However, when 
intracellular iron levels are high, the IRE binding site of IRP1 associates with an iron-sulfur cluster and 
thus changes the IRE-binding site into an aconitase active unit [14] with no affinity for IREs. IRP2 
does not convert into an aconitase. Instead, when iron levels are high, IRP2 is degraded by an ubiquitin 
ligase protein complex [15]. This complex contains an iron-responsive domain that is crucial for IRP2 
degradation [16]. It is clear that the action of IRPs is very important in regulating the mRNA and 
protein levels of many iron absorption-related proteins. Since several of these proteins also appear to 
be regulated by ascorbate, we were eager to investigate additional factors. Here, we suggest that IRP2 
and HIF2α are involved in the regulation of basolateral transport of iron through ferroportin in 
response to ascorbate in the human intestinal Caco-2 cell model. We also compare the difference in 
protein expression depending on if the cells were grown on a permeable filter support or attached to  
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an impermeable plastic surface. Both these methods are frequently used, but unfortunately give 
different results. 
2. Materials and Methods 
2.1. Materials 
Polystyrene disposables for cell cultivation were produced by Corning (San Fransisco, MA, USA). 
Media, supplements, and other reagents for culture maintenance were obtained from PAA (Pasching, 
Austria). Reagents used for the cell experiments were bought from Sigma Aldrich (Schnelldorf, 
Germany). All components for the enzyme-linked immuno-sorbent assay (ELISA) analyses, except for 
the primary antibodies, were purchased from Invitrogen (Paisley, UK). Ascorbate was used in the form 
of sodium ascorbate and iron was added as Fe(II)Cl2·4H2O labeled with 55FeCl3. 
2.2. Antibodies 
All antibodies were commercially produced, tested, and recommended for the application. The 
primary capture antibodies in the ELISA analyses were rabbit anti-human ferroportin peptide 
(ab58695; Abcam, Cambridge, UK), rabbit anti-human IRP2 (LS-C80347, LifeSpan Biosciences, 
Seattle, WA, USA), rabbit anti-human HIF2 (ab73895; Abcam, Cambridge, UK). Mouse anti-human 
Immunoglobin G (IgG) conjugated with horseradish peroxidase (HRP; #55788; BD, Franklin Lakes, 
NJ, USA) was used as secondary capture antibody. The primary antibody used in the Western blot 
analyses was a rabbit anti-human ferroportin (NBP1-21502; Novus Biologicals, Littleton, MA, USA). 
A rabbit anti-human β-actin antibody (ab8227; Abcam, Cambridge, UK) was used as loading control. 
For Western blot analyses, the secondary antibody was goat anti-rabbit IgG conjugated to HRP  
(Bio-Rad, Sundbyberg, Sweden). Primary and secondary antibodies were used at 1 μg/mL. 
2.3. Cell Line 
Caco-2 cells (HTB-37) were obtained from the American Type Culture Collection (Rockville, MD, 
USA) at passage 20. Stock cultures were maintained in Dulbecco’s modified Eagle’s medium 
supplemented with fetal bovine serum (FBS; 16%) and non-essential amino acids (0.9%). The medium 
contained an agent for the prevention of bacterial, fungal, or mycoplasma infection; Normocin 
(Invivogen, San Diego, CA, USA). The cell cultures were incubated at 37 °C in 95% humidified air 
and 5% CO2. The medium was changed every second or third day and the cells were passaged at 
approximately 80% confluence. At passage 29–39, the cells were seeded in 12-well plates with 
Transwell® polycarbonate inserts (Corning, San Fransisco, MA, USA (0.4 μm) at 60,000 cells/insert or 
without inserts at 200,000 cells/well. All experiments were carried out 14 days after seeding. Aspirated 
medium samples were streaked on tryptone glucose extract agar plates to verify the absence of 
bacterial/fungal infections. 
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2.4. Cell Culture and Iron-Uptake Experiments 
Thirteen days after seeding, the basal medium was exchanged for minimal essential medium 
(MEM) with Earle’s salt (E15-825; PAA, Pasching, Austria) supplemented with 2% FBS. The apical 
medium was changed to unsupplemented MEM. The cells were treated with sodium ascorbate by 
adding 5 μL of a stock solution to the basal or apical medium to obtain the final concentrations of  
0, 100, 150, 200, 300, or 400 μM). The iron-uptake experiments were conducted on day 14 after 24 h 
of ascorbate supplementation. The apical medium in all plates was exchanged for freshly prepared 
MEM, unsupplemented or supplemented with iron. The iron concentration in apical chambers was  
20 μM and the cells were incubated with iron for 2 h during agitation (25 rpm; 37 °C). The integrity of 
the monolayers was verified by trans-epithelial electrical resistance (TEER) measurements to ensure 
that the epithelial layers were intact. 
2.5. Harvesting of Caco-2 Cells for Protein Analysis 
Prior to harvest, the medium was aspirated and the cells were washed in PBS. Cells were lysed in 
cold RIPA buffer (Sigma Aldrich, Schnelldorf, Germany) containing an EDTA-free protease inhibitor 
cocktail (40 μL/mL) (Roche, Basel, Switzerland). Total cellular protein content was estimated by the 
bicinchoninic acid assay (Pierce, Chicago, IL, USA). 
2.6. Sandwich ELISA for Estimation of Ferroportin, IRP2, and HIF2α Protein Expression 
The Amplex® ELISA development kit (Invitrogen, Paisley, UK) was used according to 
manufacturer’s protocol, with modifications. Briefly, microplates were coated with capture antibodies 
(rabbit anti-human IRP2, HIF2α, and ferroportin) at 1 μg/mL (overnight, 4 °C). The plates were 
washed in PBS tween and blocked in PBS-BSA 1% (overnight, 4 °C). After washing, 10 μL of sample 
in PBS-BSA (0.1%) was added to each well for incubation (1 h). The wells were washed once again 
and, incubated with the secondary capture antibody (mouse-anti-human IgG-HRP) for 30 min. After 
the final washing step, the wells were added the reaction mixture containing the Amplex® UltraRed 
reagent. The signal was detected after 30 min with a fluorescence plate reader (excitation wavelength 
530 nm/emission wavelength 590 nm; Tecan GmbH, Salzburg, Austria). The fluorescence gain from 
the samples was normalized to the total protein concentration in each sample. 
2.7. SDS-PAGE and Western Blot for Detection of Ferroportin Levels 
Cell lysates were diluted in 2× Laemmli sample buffer with β-mercaptoethanol and boiled at 95 °C 
for 5 min. Samples (20 μg protein) were loaded on TGX-gels (any kD; Bio-rad, Sundbyberg, Sweden) 
and electrophoresed with Tris/glycine/SDS buffer at 200 V. The molecular weight standard was a 
Precision Plus Protein Western C standard. After electrophoresis, the separated proteins were blotted to 
a polyvinyl difluoride (PVDF) membrane using the Trans-Blot Turbo system with pre-packed transfer 
packs and the 3-min protocol (Bio-rad). The blots were incubated in blocking buffer (Sigma Aldrich, 
Schnelldorf, Germany) at room temperature for 1 h. The primary antibody was diluted in blocking 
buffer (1 μg/mL) and the incubation lasted for 1 h or overnight at 4 °C. Then, the blots were washed in 
PBS-tween 20 (5 × 10 min, 25 rpm). The blots were incubated with secondary antibody (1 μg/mL) and 
Nutrients 2014, 6 253 
 
a StrepTactin-HRP conjugate (2 μL) for 1 h. A strenuous washing protocol was used (5 × 10 min,  
40 rpm). Finally, the blots were added a solution of luminol and peroxide buffer (Bio-rad) and the 
bands were detected by the ChemiDoc™ XRS+ system (Bio-rad) and analyzed with the software 
Image Lab™ 3.0.1 (Bio-rad). 
2.8. 55Fe Transmembrane Transport 
Caco-2 cells were cultured on permeable polycarbonate inserts as described in a former section, the 
only difference being that the medium contained no antibiotics. On day 13, 6 (or 2) sets of cells were 
either treated for 19 h with ascorbate (150 μM) in the basal chamber or left untreated before 
commencement of the iron-uptake studies. The cells were exposed to a solution of FeCl2 labeled with 
55FeCl3 for 2 h (total iron was 20 μM and the activity was 5.4 Mbq/mL). 55FeCl3 was stabilized in 
nitrilotriacetate at a ratio of 1:4 before addition to the FeCl2 solution, which was allowed to equilibrate 
for 1 h before incubation with the cells. Uptake of 55Fe and transfer from the cells to the basolateral 
chamber, were measured by counting β-emission using a Tri-Carb 1900CA liquid scintillation analyzer 
(Packard Instrument, Meriden, CT, USA). 
2.9. RNA Purification and cDNA Synthesis 
Cellular RNA was purified using the RNeasy® Mini Kit (Qiagen Gmbh, Hilden, Germany) 
according to the manufacturer’s instructions. An optional on-column DNase digestion was also 
conducted (Qiagen cat. no. 79254). Flow-throughs were discarded by vacuum assisted aspiration and 
the procedure was conducted under laminar airflow. In the last step, the columns were transferred to 
new collection tubes (Biopure; Sigma Aldrich, St. Louis, MO, USA) and RNase free water (50 μL) 
was added directly to the membrane. The RNA was eluted by centrifugation for 1 min at 8000 g. The 
samples were frozen in −80° until further analyses. The RNA concentration in samples diluted in  
Tris-HCl (10 mM, pH 7.0) was determined spectrophotometrically at 260 nm using a Tecan Sapphire II 
fluorescence microplate reader (Tecan Gmbh, Salzburg, Austria). The purity of the samples was 
evaluated by measuring the absorbance ratio of 260/280 nm. Single-stranded cDNA was synthesized 
using a commercial kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s 
instructions. The reverse transcription was performed using a thermal cycler (Bio-rad Gene cycler™, 
Hercules, CA, USA). 
2.10. Real Time PCR Measurements of Ferroportin mRNA Expression 
For real time PCR (qPCR), The TaqMan gene expression system was employed. TaqMan Gene 
Expression Master Mix (Applied Biosystems, Foster City, CA, USA) was used following the 
manufacturer’s instructions. The ferroportin primer pair and probe (ref number Hs00205888_m1) was 
selected together with the human GAPD (GAPDH, FAM/MGB Probe, Non-Primer Limited  
reference no.: 4333764F) as the internal control. Target and controls were run in separate wells. For 
each amplification, 1 or 3 ng cDNA was used in a reaction volume of 20 μL. For thermocycling, a 
Stratagene MX 3005P instrument (SA Biosciences, Frederick, MD, USA) was used. The PCR started 
with incubation at 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C for 60 s.  
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The fluorescence detection was done in each cycle at 60 °C. PCR-products were visualized on an 
ethidium-stained TAE-agarose gel (1%) using the Gel Doc 2000 equipment (Bio-rad, Hertfordshire, UK). 
2.11. Statistics 
Calculated values are presented as means ± standard deviation (SD). Cell experiments were made in 
triplicates and repeated at three occasions. Number of replicas are stated as n = x. The significance of 
the difference between treatment and control was analyzed by Student’s two-tailed, unpaired t test 
using Microsoft Office Excel 2010 or 2011. Differences were considered significant at p < 0.05. 
3. Results 
3.1. Ferroportin, IRP2, and HIF2α Levels Peaked at 100 μM of Ascorbate 
In the initial experiments we observed that enterocyte ferroportin levels were increased in the 
presence of ascorbate, added to the basal medium of membrane-cultured cells at 150 μM (28% ± 4%,  
p = 0.04, n = 12) and decreased in the presence of iron (20 μM) in combination with ascorbate  
(150 μM, Figure 1). We have also learnt that doubling the concentration of ascorbate (300 μM)  
down-regulates ferroportin levels (unpublished data) [17]. In the present work, we have therefore 
investigated ferroportin, IRP2, and HIF2α protein expression in a range of basally added ascorbate 
concentrations (0, 100, 200, and 400 μM). The results indicate that ferroportin levels peak at 100 μM 
ascorbate with an increase of 274% (p = 0.02, n = 6), as shown in Figure 2a. Increases were also 
observed for IRP2 (230%, p = 0.0009, n = 6) and HIF2α (69%, p = 0.03, n = 6). The levels of HIF2α at 
200 and 400 μM ascorbate were insignificantly increased by 28% and 34% (p = 0.22 and p = 0.14,  
n = 6) from the baseline. In similar experiments, using Caco-2 cells cultured directly on the bottom of 
the wells, there was no observable difference in ferroportin levels at any concentration of ascorbate 
(Figure 2b). The IRP2 levels were not significantly increased at 100 μM (76%, p = 0.11, n = 6), in 
contrast to the insert-cultured cells. However, HIF2α levels were significantly amplified at 100 μM 
(295%, p = 0.02, n = 6), which may suggest that HIF2α is not as sensitive to enterocyte iron levels as 
ferroportin or IRP2, which will be discussed later on. 
3.2. Increased Ferroportin Levels, Increased Transmembrane Fe Transport 
The cell lysates, basal, and apical media were analyzed for ascorbate/dehydroascorbate levels as 
described previously [9] using the method of Margolis et al. [18]. The intracellular ascorbate 
concentrations referring to Figure 2a,b are presented in Figure 2c. In the experiments at 150 μM of 
ascorbate (Figures 1 and 3), the intracellular ascorbate levels in control cells were on average  
0.8 ng/mg protein and in ascorbate-incubated cells (150 μM) the levels were on average 0.9 μg/mg 
protein. In the experiments, we used serum-free MEM in the apical medium and MEM-FBS 2% in the 
basal medium. We found that the apical medium was devoid of ascorbate/dehydroascorbate (data not 
shown), indicating that there was no transport of ascorbate from the cell interior to the apical surface. 
Thus, when iron was provided in the apical chamber and ascorbate in the basal chamber, there was no 
enhancement of iron uptake due to direct reduction of Fe3+ to Fe2+ by apical (lumenal) ascorbate. In 
these experiments, we investigated if increased ferroportin levels (30%, by ascorbate at 150 μM) had 
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any functional implication in that iron transport would be facilitated. Ascorbate-replete cells were 
treated with apical iron (20 μM, 2 h) and iron uptake and basal transport was measured by means of 
radiolabeled iron (55Fe), which yielded a significant increase in iron uptake (28%; from 0.09 ± 0.015 to 
0.11 ± 0.02 nmol Fe/mg protein, p = 0.04) and in basal transfer (19%; from 1.89 ± 0.26 to  
2.25 ± 0.15 pmol Fe/mg protein, p = 0.03, n = 8, Figure 3a,b). The increase in iron uptake supports 
previous results, which showed that the apical iron transporter DMT1 (Nramp2) and the intracellular 
iron storage protein ferritin, were up-regulated in the presence of ascorbate [9]. The increase in 
basolateral transfer may be greater in reality, due to a possible underestimation of the transmembrane 
basal transport of iron using the present method [19]. The ferroportin protein levels were visualized by 
Western Blot before treating the cells with ascorbate (150 μM) and after ascorbate (150 μM) and iron 
(20 μM) incubation as shown in Figure 3c. 
Figure 1. Sodium ascorbate (150 μM) was added to the apical and/or basal medium of 
Caco-2 cells cultured on permeable Transwell® inserts. Ferroportin protein expression was 
measured with ELISA. Data are means ± SD, n = 12. Significant differences from the 
baseline (0 μM) are labeled with an asterisk (*). A western blot of ferroportin at the 
corresponding treatments is shown above the graph. 
 
Figure 2. (a) Sodium ascorbate was added to the basal medium of Caco-2 cells cultured on 
permeable Transwell® inserts. HIF2, IRP2, and ferroportin protein expression was 
measured with a sandwich ELISA. Data are means ± SD, n = 6. Significant differences 
from the baseline (0 μM) are labeled with an asterisk (*). (b) The same experiments as in 
(a) were repeated using Caco-2 cells cultured directly on the bottom of the wells. Instead of 
basal addition of sodium ascorbate, ascorbate was added to the apical medium. (c) 
Intracellular ascorbate levels of cells treated with sodium ascorbate (0, 100, 200, and  
400 μM). Data are means ± SD, n = 3. 
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Figure 2. Cont. 
Figure 3. Iron (55Fe) transport across the apical and basal borders. (a) Apical transport 
(uptake) of 55Fe in response to intracellular/basal ascorbate (150 μM) was increased 
compared to no ascorbate. The cells were incubated with ascorbate in the basal chamber for 
24 h. Values are means of 10 samples ±SD. The difference between treatments was 
significant (p = 0.04). (b) Basolateral transport of iron (as 55Fe) in response to 
intracellular/basal ascorbate (150 μM) was increased compared to no ascorbate. The cells 
were incubated with ascorbate in the basal chamber for 24 h. Values are means of  
10 samples ±SD. The difference between treatments was significant (p = 0.03). (c) Western 
Blot of cells treated with ascorbate (150 μM). Lane 1: Control cells (no treatment). Lane 2: 
Basal ascorbate at 150 μM; these were the ferroportin levels before iron addition in (a). 
Lane 3: Ferroportin levels 22 h after the iron addition (20 μM for 2 h) in (a). 
3.3. Ferroportin mRNA Levels Were Unchanged at 150 μM Ascorbate 
We also measured the ferroportin mRNA expression in cells exposed to sodium ascorbate (150 μM 
for 24 h) and/or iron (20 μM for 2 h). The q-PCR analysis showed that there were only minor and 
statistically insignificant changes for all treatments (data not shown). To affect the RNA expression, 
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more strenuous treatments seem to be required. In a study by Martini et al. [20], Caco-2 cells were 
exposed to ascorbate (1 mM) together with iron (200 μM) for 72 h. This treatment caused a  
down-regulation of ferroportin mRNA-levels. 
4. Discussion 
4.1. The Effects of Ascorbate—Just a Change in Redox Balance of the Cell? 
Ascorbate is an important lumenal reducing agent for ferric iron (Fe3+) and copper (Cu+) to make 
these ions available for the cellular uptake proteins. However, ascorbate is also an important 
intracellular co-factor for the reductase DCYTB to which it distributes electrons to aid the enzymatic 
reduction of Fe3+ in the lumenal membrane of human enterocytes [21]. Ascorbate initially increases the 
cellular levels of DCYTB and iron uptake via DMT1, in addition to increasing the efflux of iron by 
ferroportin. Hypothetically, if the net cellular levels of iron would increase until steady state is 
reached, the excessive iron should be directed for incorporation in ferritin molecules (we have 
observed increases in ferritin levels), leaving “normal” iron levels in the labile iron pool (LIP). 
However, the redox state of iron in the LIP may thus have moved towards the reduced ferrous state 
(Fe2+) and the cells may sense the increase in Fe2+ as an increase in iron load, which may be a plausible 
explanation since ferroportin transports Fe2+ and not Fe3+. In fact, such an increase of Fe2+ in the LIP in 
ascorbate-replete, compared to ascorbate-deficient cells has been observed in brain cells (astrocytes) [22]. 
This would explain the down-regulation of IRP2 protein levels at higher concentrations of ascorbate. It 
would not explain the decreasing ferroportin levels while IRP2 is decreasing. If the ascorbate effect 
was only an increase in available iron, the degradation of IRP2 should instead promote ferroportin 
translation and thus increase its abundance. It seems more likely that ascorbate causes an iron-independent 
activation of the RNA-binding activity of IRP2 by the reduction of cysteine residues near the  
IRE-binding site [23], which blocks the translation of ferroportin mRNA. This results in a down-regulation 
of both IRP2 and ferroportin protein levels as observed here. That the ascorbate-induced down-regulation 
of ferroportin levels is a posttranscriptional event is also supported by the mRNA expression data, 
which suggested that ascorbate (150 μM) did not affect the cellular ferroportin mRNA content. 
Recently, it was shown that intracellular ascorbate facilitates uptake of transferrin-bound iron (Tf-59Fe) 
in cell types of non-enterocyte origin, and interestingly that it was independent of a general increase in 
cellular reducing capacity [24]. It remains to be evaluated if this is also true for intestinal absorptive 
cells. In summary, once the cells sense an increased iron load, increasing intracellular concentrations 
of ascorbate down-regulate ferroportin and its transport of iron. The initial increase of ferroportin 
levels from 0 to 100 μM of ascorbate is harder to explain; the effects we observe are the effects we 
would expect in iron-deficient cells. However, it seems unlikely that the cells would be more iron 
deficient at 100 μM of ascorbate compared to control cells with no ascorbate addition at all. The 
question is why all these iron-absorption associated proteins (DMT1, DCYTB, ferritin, ferroportin, 
IRP2, and HIF2α) increase with “low” concentrations of ascorbate? 
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4.2. Insights from Comparison of Permeable and Impermeable Basal Support for Cell Cultures 
Cell monolayers cultured on permeable Transwell® inserts have access to nutrients from both sides 
of the polarized cells. In addition, the absorptive enterocyte is specialized in transporting nutrients 
from the apical side across the cell and the basal membrane. It also responds to the systemic 
requirements of iron to increase or decrease apical to basal transport of iron. Translated into cell 
culture, this implicates that if an iron-free basal medium is used, systemic iron deficiency is implied 
and an apical to basal iron surge is induced. Similarly, if the cells are growing in high-iron medium or 
on an impermeable support, less or no apical to basal transport is facilitated, which traps iron inside  
the enterocyte. In the present work, we observed a distinct difference in cellular ferroportin levels in 
insert-cultured cells compared to bottom-grown cells. In cells growing on impermeable supports, 
ferroportin levels were unchanged, independent on ascorbate concentration. Also, the general 
expression of the investigated proteins, normalized to total cellular protein, was only a third of the 
expression in the insert-cultured cells. A similar trend for IRP2 levels as in insert-cultured cells could 
be anticipated, but the changes were insignificant for all ascorbate concentrations. In all, this may be 
interpreted as an inability of bottom-grown cells to respond fully to the increased iron load caused by 
ascorbate effects on DMT1 in combination with the entrapment. In contrast, HIF2α was significantly 
increased at ascorbate (100 μM) in both culture systems, suggesting that HIF2α is not as sensitive to 
the enterocyte intracellular iron concentration as ferroportin and IRP2. HIF2α has been shown to 
increase during iron deficiency in mice, and appears to be regulated by systemic iron load [25]. 
5. Conclusions 
Our findings indicate that intracellular/basolateral ascorbate status regulates the transport of iron 
through ferroportin across the basal border of intestinal Caco-2 cells. The ascorbate effect, caused by 
the higher concentrations of ascorbate in the present work, may be a dual effect on IRP2, which 
expression decreases due to a sensed increase in iron load while the reducing capacity of ascorbate 
activates the iron-independent RNA-binding activity of IRP2, which blocks ferroportin translation. 
This results in down-regulation of both IRP2 and ferroportin protein levels as observed here. The 
initial up-regulating effect of ascorbate on ferroportin and IRP2 levels are likely to be the cause of 
cellular iron deficiency, which increases HIF2α levels. The increase in HIF2α up-regulates the 
ferroportin and IRP2 expression. However, we are at the moment not able to explain the peaking effect 
of ferroportin, IRP2, or HIF2α by ascorbate at 100 μM. Further studies are needed. 
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